Abstract
A new ligand DBHIP and its two ruthenium(II) complexes [Ru(dmb)2(DBHIP)](ClO4)2 (1) and [Ru(dmp)2(DBHIP)](ClO4)2 (2) have been synthesized and characterized. The cytotoxicity of DBHIP and complexes 1 and 2 has been assessed by MTT assay. The apoptosis studies were carried out with acridine orange/ethidium bromide (AO/EB) staining methods. The binding behaviors of these complexes to calf thymus DNA (CT-DNA) were studied by absorption titration, viscosity measurements, thermal denaturation and photoactivated cleavage. The DNA-binding constants of complexes 1 and 2 were determined to be 8.64 ± 0.16 × 104 (s = 1.34) and 2.79 ± 0.21 × 104 (s = 2.17) M−1. The results suggest that these complexes interact with DNA through intercalative mode. The studies on the mechanism of photocleavage demonstrate that superoxide anion radical (O2 •–) and singlet oxygen (1O2) may play an important role in the DNA cleavage. The experiments on antioxidant activity show that these compounds also exhibit good antioxidant activity against hydroxyl radical (OH•).
Similar content being viewed by others
Abbreviations
- DBHIP:
-
2-(3,5-Dibromo-4-hydroxyphenyl)imidazo[4,5-f][1,10]phenanthroline
- dmb:
-
4,4′-Dimethyl-2,2′-bipyridine
- dmp:
-
2,9-Dimethyl-1,10-phenanthroline
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- AO/EB:
-
Acridine orange/ethidium bromide
- DMSO:
-
Dimethyl sulfoxide
- RPMI:
-
Roswell Park Memorial Institute
- DMF:
-
N,N-Dimethylformamide
- CT-DNA:
-
Calf thymus DNA
- MLCT:
-
Metal to ligand charge transfer
- Tris:
-
Tris(hydroxymethyl)aminomethane
- ES–MS:
-
Electrospray mass spectroscopy
- NAMI-A:
-
[ImH][trans-RuCl4(DMSO)(Im)]
- KP1019:
-
[IndH][trans-RuCl4(Ind)2]
References
Arockiasamy DL, Radhika S, Parthasarathi R, Nair BU (2009) Synthesis and DNA-binding studies of two ruthenium(II) complexes of an intercalating ligand. Eur J Med Chem 44:2044–2051. doi:10.1016/j.ejmech.2008.10.013
Barton JK, Raphael AL (1984) Photoactivated stereospecific cleavage of double-helical DNA by cobalt(III) complexes. J Am Chem Soc 106:2466–2468. doi:10.1021/ja00320a058
Carter MT, Rodriguez M, Bard A (1989) Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2′-bipyridine. J Am Chem Soc 111:8901–8911. doi:10.1021/ja00206a020
Chaires JB, Dattagupta N, Crothers DM (1982) Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on the interaction of daunomycin with deoxyribonucleic acid. Biochemistry 21:3933–3940. doi:10.1021/bi00260a005
Chen LM, Liu J, Chen JC, Shi S, Tan CP, Zheng KC, Ji LN (2008) Experimental and theoretical studies on the DNA-binding and spectral properties of water-soluble complex [Ru(MeIm)4(dpq)]2+. J Mol Struct 881:156–166. doi:10.1016/j.molstruc.2007.09.010
Cheng CC, Rokita SE, Burrows CJ (1993) Nickel(III)-promoted DNA cleavage with ambient dioxygen. Angew Chem Int Ed Engl 32:277–278. doi:10.1002/anie.199302771
Cocchietto M, Sava G (2000) Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice. Pharmacol Toxicol 87:193–197. doi:10.1191/1078155204jp118oa
Cohen G, Eisenberg H (1969) Viscosity and sedimentation study of sonicated DNA-proflavine complexes. Biopolymers 8:45–49. doi:10.1002/bip.1969.360080105
Collin JP, Sauvage JP (1986) Synthesis and study of mononuclear ruthenium(II) complexes of sterically hindering diimine chelates. Implications for the catalytic oxidation of water to molecular oxygen. Inorg Chem 25:135–141. doi:10.1021/ic00222a008
Dougan SJP, Sadler PJ (2007) The design of organometallic ruthenium arene anticancer agents. Chimia 61:704–715. doi:10.2533/chimia.2007.704
Dyson PJ (2007) Systematic design of a targeted organometallic antitumour drug in pre-clinical development. Chimia 61:698–703. doi:10.2533/chimia.2007.698
Erkkila KE, Odom DT, Barton JK (1999) Recognition and reaction of metallointercalators with DNA. Chem Rev 99:2777–2796. doi:10.1021/cr9804341
Friedman AE, Chambron JC, Sauvage JP, Turro NJ, Barton JK (1990) A molecular light switch for DNA: Ru(bpy)2(dppz)2+. J Am Chem Soc 112:4960–4962. doi:10.1021/ja00168a052
Gao F, Chao H, Wang JQ, Yuan YX, Sun B, Wei YF, Peng B, Ji LN (2007) Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes. J Biol Inorg Chem 12:1015–1027. doi:10.1007/s00775-007-0272-4
Ghosh A, Mandoli A, Kumar DK, Yadav NS, Ghosh T, Jha B, Thomas JA, Das A (2009) DNA binding and cleavage properties of a newly synthesised Ru(II)-polypyridyl complex. Dalton Trans 42:9312–9321. doi:10.1039/b906756f
Habtemariam A, Melchart M, Fernandez R, Parsons S, Oswald IDH, Parkin A, Fabbiani FPA, Davidson JE, Dawson A, Aird RE, Jodrell DI, Salder PJ (2006) Structure–activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands. J Med Chem 49:6858–6868. doi:10.1021/jm060596m
Hartinger CG, Zorbas-Seifried S, Jakupec MA, Zorbas H, Kepper BK (2006) From bench to bedside—preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). J Inorg Biochem 100:891–904. doi:10.1016/j.jinorgbio.2006.02.013
Hotze ACG, Caspers SE, de Vos D, Kooijman H, Spek AL, Flamigni A, Bacac M, Sava G, Haasnoot JG, Reedijk JJ (2004) Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L = o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]. J Biol Inorg Chem 9:354–364. doi:10.1007/s00775-004-0531-6
Huang HL, Tang GP, Wang QQ, Li D, Shen FP, Zhou J, Yu H (2006) Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-b-cyclodextrin or (2-hydroxypropyl)-c-cyclodextrin. Chem Commun 22:2382–2384. doi:10.1039/b601130f
Lesko SA, Lorentzen RJ, Ts’o PO (1980) Role of superoxide in deoxyribonucleic acid strand scission. Biochemistry 19:3023–3028. doi:10.1021/bi00554a029
Li TR, Yang ZY, Wang BD, Qin DD (2008) Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth(III) complexes with naringenin-2-hydroxy benzoyl hydrazone ligand. Eur J Med Chem 43:1688–1695. doi:10.1016/j.ejmech.2007.10.006
Liu YJ, Chao H, Yuan YX, Yu HJ, Ji LN (2006) Ruthenium(II) mixed-ligand complexes containing 2-(6-methyl-3-chromonyl)imidazo[4,5-f][1,10]-phenanthroline: synthesis, DNA-binding and photocleavage studies. Inorg Chim Acta 359:3807–3814. doi:10.1016/j.ica.2006.05.015
Liu J, Zheng WJ, Shi S, Tan CP, Chen JC, Zheng KC, Ji LN (2008) Synthesis, antitumor activity and structure–activity relationships of a series of Ru(II) complexes. J Inorg Biochem 102:193–202. doi:10.1016/j.jinorgbio.2007.07.035
Liu YJ, Zeng CH, Wu FH, Yao JH, He LX, Huang HL (2009) Synthesis, characterization, photocleavage of DNA and cytotoxicity of ruthenium(II) mixed-ligand complexes. J Mol Struct 932:105–111. doi:10.1016/j.molstruc.2009.05.046
Liu YJ, Zeng CH, Huang HL, He LX, Wu FH (2010) Synthesis, DNA-binding, photocleavage, cytotoxicity and antioxidantactivity of ruthenium(II) polypyridyl complexes. Eur J Med Chem 45:564–571. doi:10.1016/j.ejmech.2009.10.043
Melchart M, Sadler PJ (2006) In: G. Jaouen (ed) Bioorganometallics: biomolecules, labeling, medicine. Wiley-VCH, Weinheim, pp 39–64
Metcalfe C, Thomas JA (2003) Kinetically inert transition metal complexes that reversibly bind to DNA. Chem Soc Rev 32:215–224. doi:10.1039/b201945k
Mosmann TJ (1983) Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors. Immunol Methods 65:55–63. doi:10.1016/0022-1759(83)90302-2
Nilsson R, Merkel PB, Kearns DB (1972) Unambiguous evidence for the participation of singlet oxygen (1) in photodynamic oxidation of amino acids. Photochem Photobiol 16:117–124. doi:10.1111/j.1751-1097.1972.tb07343.x
Reedijk J (2003) Bioinorganic chemistry special feature: new clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. Proc Natl Acad Sci USA 100:3611–3616
Reichmann MF, Rice SA, Thomas CA, Doty P (1954) A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 76:3047–3053. doi:10.1021/ja01640a067
Sarkar T, Petrov AS, Vitko JR, Santai CT, Harvey SC, Mukerji I, Hud NV (2009) Integration host factor (IHF) dictates the structure of polyamine-DNA condensates: implications for the role of IHF in the compaction of bacterial chromatin. Biochemistry 48:667–675. doi:10.1021/bi8019965
Satyanarayana S, Dabrowiak JC, Chaires JB (1993) Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. Biochemistry 32:2573. doi:10.1021/bi00061a015
Schäfer S, Ott I, Gust R, Sheldrick WS (2007) Influence of the polypyridyl (pp) ligand size on the DNA binding properties, cytotoxicity and cellular uptake of organoruthenium(II) complexes of the type [6η–C6Me6)Ru(L)(pp)]n+ [L = Cl, n = 1; L = (NH2)2CS, n = 2]. Eur J Inorg Chem 19:3034–3046. doi:10.1002/ejic.200700206
Schatzschneider U, Niesel J, Ott I, Gust R, Alborzinia H, Wölfl S (2008) Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2(N–N)]Cl2 with N–N = bpy, phen, dpq, dppz, and dppn. ChemMedChem 3:1104–1109. doi:10.1002/cmdc.200800039
Spector DL, Goldman RD, Leinwand LA (1998) In cells: a laboratory manual, vol 1. Cold Spring Harbor Laboratory Press, New York, chap 15
Steck EA, Day AR (1943) Reactions of phenanthraquinone and retenequinone with aldehydes and ammonium acetate in acetic acid solution. J Am Chem Soc 65:452–456. doi:10.1021/ja01243a043
Sullivan BP, Salmon DJ, Meyer TJ (1978) Mixed phosphine 2,2′-bipyridine complexes of ruthenium. Inorg Chem 17:3334–3341. doi:10.1021/ic50190a006
Sun B, Guan JX, Xu L, Yu BL, Jiang L, Kou JF, Wang L, Ding XD, Chao H, Ji LN (2009) DNA condensation induced by ruthenium(II) polypyridyl complexes [Ru(bpy)2(PIPSH)]2+ and [Ru(bpy)2(PIPNH)]2+. Inorg Chem 48:4637–4639. doi:10.1021/ic900102r
Tan CP, Liu J, Chen LM, Shi S, Ji LN (2008) Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. J Inorg Biochem 102:1644–1653. doi:10.1016/j.jinorgbio.2008.07.005
Tan LF, Liang XL, Liu XH (2009) Synthesis, double stranded DNA-binding and photocleavage studies of a functionalized ruthenium(II) complex with 7,7′-methylenedioxyphenyldipyrido[3,2-a:2′,3′-c]-phenazine. J Inorg Biochem 103:441–447. doi:10.1016/j.jinorgbio.2008.12.010
Velders AH, Kooijman H, Spek AL, Haasnoot JG, de Vos D, Reedijk J (2000) Strong differences in the in vitro cytotoxicity of three isomeric dichlorobis(2-phenylazopyridine)ruthenium(II) complexes. Inorg Chem 39:2966–2967. doi:10.1021/ic000167t
Vijayanathan V, Thomas T, Shirahata A, Thomas TJ (2001) DNA condensation by polyamines: a laser light scattering study of structural effects. Biochemistry 40:13644–13651. doi:10.1021/bi010993t
Vilaplana RA, González-Vilchez F, Gutiérrez-Puebla E, Ruiz-Valero C (1994) The first isolated antineoplastic Ru(IV) complex: synthesis and structure of [Cl2(1,2-cyclohexanediaminotetraacetate)Ru]·2H2O. Inorg Chim Acta 224:15–18. doi:10.1016/0020-1693(94)04159-8
Vilaplana RA, Delmani F, Manteca C, Torreblanca J, Moreno J, García-Herdugo G, González-Vilchez FJ (2006) Synthesis, interaction with double-helical DNA and biological activity of the water soluble complex cis-dichloro-1,2-propylenediamine-N,N,N′,N′-tetraacetato ruthenium(III). J Inorg Biochem 100:1834–1841. doi:10.1016/j.jinorgbio.2006.07.012
Waring MJ (1965) Complex formation between ethidium bromide and nucleic acids. J Mol Biol 13:269–281. doi:10.1016/S0022-2836(65)80096-1
Wu JZ, Ye BH, Wang L, Ji LN, Zhou JY, Li RH, Zhou ZY (1997) Bis(2,2’-bipyridine)ruthenium(II) complexes with imidazo[4,5-f][1,10]-phenanthroline or 2-phenylimidazo[4,5-f][1,10]phenanthroline. Dalton Trans 8:1395–1401. doi:10.1039/a605269j
Xu H, Zheng KC, Lin LJ, Li H, Gao Y, Ji LN (2004) Effects of the substitution positions of Br group in intercalative ligand on the DNA-binding behaviors of Ru(II) polypyridyl complexes. J Inorg Biochem 98:87–97. doi:10.1016/j.jinorgbio.2003.09.002
Yan YK, Melchart M, Habtemariam A, Sadler PJ (2005) Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Chem Commun 38:4764–4776. doi:10.1039/b508531b
Yu HJ, Huang SM, Li LY, Jia HN, Chao H, Mao ZW, Liu JZ, Ji LN (2009) Synthesis, DNA-binding and photocleavage studies of ruthenium complexes [Ru(bpy)2(mitatp)]2+ and [Ru(bpy)2(nitatp)]2+. J Inorg Biochem 103:881–890. doi:10.1016/j.jinorgbio.2009.03.005
Zeglis BM, Pierre VC, Barton JK (2007) Metallo-intercalators and metallo-insertors. Chem Commun 4565–4579. doi:10.1039/b710949k
Zorzet S, Sorce A, Casarsa C, Cocchietto M, Sava G (2001) Pharmacological effects of the ruthenium complex NAMI-A given orally to CBA mice with MCa mammary carcinoma. Met Based Drugs 8:1–7. doi:10.1155/MBD.2001.1
Acknowledgements
This work is supported by the National Nature Science Foundation of China (30800227), the Science and Technology Foundation of Guangdong Province (2009B030803057) and Guangdong Pharmaceutical University for financial support.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Liu, YJ., Liang, ZH., Li, ZZ. et al. 2-(3,5-Dibromo-4-hydroxyphenyl)imidazo[4,5-f][1,10]phenanthrolinoruthenium(II) complexes: synthesis, characterization, cytotoxicity, apoptosis, DNA-binding and antioxidant activity. Biometals 23, 739–752 (2010). https://doi.org/10.1007/s10534-010-9340-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-010-9340-2